These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 12572311)

  • 1. [Insulin pump--25 years old and with a future. It counteracts development of late diabetic complications].
    Adamson U; Lins PE
    Lakartidningen; 2002 Dec; 99(51-52):5168-70. PubMed ID: 12572311
    [No Abstract]   [Full Text] [Related]  

  • 2. [Insulin pump treatment in Denmark].
    Hermansen K; Bendtson I; Borch-Johnsen K; Christiansen JS; Henriksen JE; Lervang HH; Nørgaard K
    Ugeskr Laeger; 2004 Oct; 166(42):3685-9. PubMed ID: 15508285
    [No Abstract]   [Full Text] [Related]  

  • 3. Current status and future of implantable insulin pumps for the treatment of diabetes.
    Catargi B
    Expert Rev Med Devices; 2004 Nov; 1(2):181-5. PubMed ID: 16293038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in pump technology: insulin patch pumps, combined pumps and glucose sensors, and implanted pumps.
    Schaepelynck P; Darmon P; Molines L; Jannot-Lamotte MF; Treglia C; Raccah D
    Diabetes Metab; 2011 Dec; 37 Suppl 4():S85-93. PubMed ID: 22208717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Managing type 1 diabetes ‑ a journey from starvation to insulin pump.
    Ejaz S; Wilson T
    Minerva Endocrinol; 2013 Jun; 38(2):123-31. PubMed ID: 23732367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of CSII.
    Home PD
    Diabet Med; 2006 Jun; 23(6):707; author reply 707-8. PubMed ID: 16759317
    [No Abstract]   [Full Text] [Related]  

  • 7. [Do implantable insulin pumps have a value other than experimental?].
    Selam JL
    Ann Med Interne (Paris); 1992; 143(1):2-4. PubMed ID: 1605456
    [No Abstract]   [Full Text] [Related]  

  • 8. The dawning of a new age. The implantable insulin pump.
    Robinson LK
    Physician Assist; 1993 Apr; 17(4):91-2, 95-6, 98. PubMed ID: 10125680
    [No Abstract]   [Full Text] [Related]  

  • 9. Implantable pump therapy restores metabolic control and quality of life in type 1 diabetic patients with Buschke's nonsystemic scleroderma.
    Baillot-Rudoni S; Apostol D; Vaillant G; Brun JM; Renard E;
    Diabetes Care; 2006 Jul; 29(7):1710. PubMed ID: 16801609
    [No Abstract]   [Full Text] [Related]  

  • 10. Position statement: Continuous subcutaneous insulin infusion in very young children with type 1 diabetes.
    Eugster EA; Francis G;
    Pediatrics; 2006 Oct; 118(4):e1244-9. PubMed ID: 17015512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diabetes simulation model].
    Johansen K
    Ugeskr Laeger; 2010 Aug; 172(35):2404; author reply 2404. PubMed ID: 20848687
    [No Abstract]   [Full Text] [Related]  

  • 12. The cost-effectiveness of continuous subcutaneous insulin infusion compared with multiple daily injections for the management of diabetes: response to Scuffham [corrected] and Carr.
    Palmer AJ; Roze S; Valentine WJ; Spinas G
    Diabet Med; 2004 Dec; 21(12):1372; author reply 1372-3. PubMed ID: 15569145
    [No Abstract]   [Full Text] [Related]  

  • 13. [Personal insulin pumps--from experiment research till recommended method of diabetes treatment].
    Mozdzan M; Ruxer J; Loba J
    Pol Merkur Lekarski; 2005 Oct; 19(112):577-9. PubMed ID: 16379330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. It's time to reconsider the implantable insulin pump.
    Buchwald H; Rohde TD
    ASAIO J; 1994; 40(4):917-8. PubMed ID: 7858324
    [No Abstract]   [Full Text] [Related]  

  • 15. The artificial pancreas: how close are we to closing the loop?
    Clarke WL; Kovatchev B
    Pediatr Endocrinol Rev; 2007 Jun; 4(4):314-6. PubMed ID: 17643078
    [No Abstract]   [Full Text] [Related]  

  • 16. [The use of continuous subcutaneous insulin infusion (CSII) with personal insulin pumps in the treatment of children and adolescents with diabetes type 1].
    Jarosz-Chobot P
    Wiad Lek; 2004; 57(5-6):263-6. PubMed ID: 15518073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous subcutaneous insulin infusion with short-acting insulin analogues or human regular insulin: efficacy, safety, quality of life, and cost-effectiveness.
    Radermecker RP; Scheen AJ
    Diabetes Metab Res Rev; 2004; 20(3):178-88. PubMed ID: 15133748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin therapy of diabetes with implantable infusion pumps: clinical aspects.
    Selam JL
    Int J Artif Organs; 1990 May; 13(5):261-6. PubMed ID: 2194976
    [No Abstract]   [Full Text] [Related]  

  • 19. Influence of abdominal location of the catheter on the efficacy of intraperitoneal insulin infusion using implantable and programmable pumps in type I diabetes.
    Pinget M; Jeandidier N; Keipes M; Louy S; Vetter A
    Transplant Proc; 1992 Jun; 24(3):945-6. PubMed ID: 1604676
    [No Abstract]   [Full Text] [Related]  

  • 20. Simulation based cost-benefit analysis of a telemedical system for closed-loop insulin pump therapy of diabetes.
    Bott OJ; Hoffmann I; Bergmann J; Kosche P; von Ahn C; Mattfeld DC; Schnell O; Pretschner DP
    Stud Health Technol Inform; 2006; 124():435-40. PubMed ID: 17108558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.